Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Motion correction of 3D dynamic contrast-enhanced ultrasound imaging without anatomical B-Mode images: Pilot evaluation in eight patients.

Medical physics·2024
Same author

Validation of a Resectability Scoring System for Prediction of Pancreatic Adenocarcinoma Surgical Outcomes.

Annals of surgical oncology·2023
Same author

Differentiation of benign from malignant solid renal lesions using CT-based radiomics and machine learning: comparison with radiologist interpretation.

Abdominal radiology (New York)·2022
Same author

Color Doppler Imaging of Vascular Abnormalities of the Uterus.

Ultrasound quarterly·2022
Same author

Evaluation of early sonographic predictors of gangrenous cholecystitis: mucosal discontinuity and echogenic pericholecystic fat.

Abdominal radiology (New York)·2022
Same author

Quantitative image features from radiomic biopsy differentiate oncocytoma from chromophobe renal cell carcinoma.

Journal of medical imaging (Bellingham, Wash.)·2021

Related Experiment Video

Updated: Jun 3, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Incidentally discovered solid pancreatic masses: imaging and clinical observations.

Margaret Goodman1, Jürgen K Willmann, R Brooke Jeffrey

  • 1Department of Radiology, Stanford University, CA 94305-5105, USA.

Abdominal Imaging
|March 12, 2011
PubMed
Summary

Incidentally discovered solid pancreatic masses are malignant, including adenocarcinomas and neuroendocrine tumors. These lesions are often aggressive, unlike cystic pancreatic lesions.

More Related Videos

Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection
05:49

Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection

Published on: November 1, 2021

Related Experiment Videos

Last Updated: Jun 3, 2026

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models
09:18

Multianimal Magnetic Resonance Imaging for Tumor Measurements in Pancreatic Cancer Mouse Models

Published on: February 3, 2026

Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection
05:49

Generation of an Orthotopic Xenograft of Pancreatic Cancer Cells by Ultrasound-Guided Injection

Published on: November 1, 2021

Area of Science:

  • Gastroenterology
  • Oncology
  • Radiology

Background:

  • Incidental findings of pancreatic masses on CT scans require careful evaluation.
  • Solid pancreatic lesions can be challenging to detect, especially when isoattenuating.

Purpose of the Study:

  • To review CT findings and clinical outcomes of patients with incidentally discovered solid pancreatic masses.
  • To characterize the nature and behavior of these incidental pancreatic neoplasms.

Main Methods:

  • Retrospective review of 24 patients with incidentally detected solid pancreatic masses over an 8-year period (2001-2009).
  • Analysis of CT features, indications for initial CT, and clinical follow-up.
  • Determination of patient demographics including age and sex.

Main Results:

  • All solid pancreatic masses identified were malignant (14 adenocarcinomas, 10 neuroendocrine tumors).
  • Common indications for CT included extrapancreatic malignancy surveillance and hematuria evaluation.
  • Subtle CT signs were crucial for detecting isoattenuating masses, with a mean survival of 21.6 months for adenocarcinoma and 42 months for neuroendocrine tumors.

Conclusions:

  • Incidental solid pancreatic masses represent malignant neoplasms, specifically ductal adenocarcinomas or neuroendocrine tumors.
  • These solid lesions are frequently biologically aggressive, contrasting with incidentally found cystic lesions.